Brianna Paesano, PA
Medical · Stamford, CTNPI 1518522176
Payments from drug & device makers
Across 1,006 payments — averaging $152.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$106K
- LEO Pharma Inc.$37K
- Johnson & Johnson$3K
- AbbVie$2K
- Incyte Corporation$743
- Sun Pharmaceutical Industries Inc.$741
- plus $4K from 24 others
What the payments were for
- Consulting fees$6,5624%
- Speaking & faculty fees$113,87774%
- Travel & lodging$17,09911%
- Food & beverage$14,94210%
- Education$6840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 300 | $106,192 |
| LEO Pharma Inc. | 101 | $36,855 |
| Johnson & Johnson | 151 | $2,663 |
| AbbVie(2 entities) | 121 | $1,791 |
| Incyte Corporation | 46 | $743 |
| Sun Pharmaceutical Industries Inc. | 45 | $741 |
| Novartis | 26 | $478 |
| Pfizer | 19 | $457 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 36 | $452 |
| Galderma Laboratories, L.p. | 24 | $391 |
| Regeneron Healthcare Solutions, Inc. | 20 | $372 |
| Arcutis Biotherapeutics, Inc. | 19 | $329 |
| Sanofi | 18 | $316 |
| UCB, Inc. | 17 | $251 |
| Dermavant Sciences, Inc. | 15 | $202 |
| E.r. Squibb & Sons, L.L.C. | 8 | $133 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Amgen | 6 | $104 |
| Mayne Pharma Commercial LLC | 7 | $97 |
| Verrica Pharmaceuticals Inc. | 4 | $80 |
| Boehringer Ingelheim | 4 | $78 |
| Journey Medical Corporation | 3 | $57 |
| EPI Health, LLC | 4 | $53 |
| Organon | 2 | $44 |
| Botanix SB Inc | 2 | $43 |
| VYNE Pharmaceuticals Inc. | 3 | $42 |
| LNHC, Inc | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
| Chiesi USA, Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$153,164 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 34 | $2,160 |
| Triamcinolone Acetonide | 64 | $669 |
| Ketoconazole | 42 | $592 |
| Betamethasone Dipropionate | 12 | $346 |
| Doxycycline Hyclate | 15 | $164 |
| Mupirocin | 13 | $86 |
| Hydrocortisone | 16 | $56 |
Paid to pharmacies, not to this prescriber.
Other medical in Stamford
- Shilpa DesaiStamford$215K
- Gregory RauNew Haven$211K
- John JasinskiNorwalk$185K
- Debra SullivanDerby$100K
- Ryan DonovanNew Haven$75K
- Jonica PagnuccoWaterbury$32K
- Alyssa GreenleafSouthington$26K
- Mark VolpeSuffield$21K
- Josephine DiazSuffield$20K
- Marissa CarignanManchester$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.